Tenure-Track, Tenure-Eligible PI Experimental Transplantation and Immunology Branch, CCR-NCI (deadline: October 1)

Imagen de Mónica Ivelisse Feliú-Mójer


The Experimental Transplantation and Immunology Branch (ETIB), Center for Cancer Research (CCR) of the National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, MD, invites applications for a tenure-eligible or tenure track principal investigator position in clinical hematopoietic stem cell transplant therapy. The applicant should have an M.D. or equivalent degree, a strong record of clinical research accomplishments, and the potential to establish a vigorous research program. The position provides salary and full funding for a translational research program, including office space, budget, support staff and research infrastructure. Salary will be commensurate with education and experience. The ETIB is dedicated to coordinated efforts in basic, preclinical and clinical investigations in the broad areas of hematopoietic stem cell transplantation. Specific areas of active research include: immune reconstitution, infections in patients with immune compromise, cytokine defined T cell subset cellular therapy, antigen discovery, antibody engineering, the molecular basis of inherited immune deficiencies, oncogenesis, chronic graft versus host disease, relapse, acute graft versus host disease prophylaxis, and cord blood transplant. Applicants with interest in these or any complimentary areas are encouraged to apply. ETIB senior staff includes Ronald Gress, Steven Pavletic, Claude Sportes, Dennis Hickstein, Juan Gea-Banacloche, Nancy Hardy, David Halverson, Christoph Rader, Fran Hakim, and William Telford. Scientific interactions are encouraged and occur extensively among members of ETIB as well as with others at NIH and extramurally. Applicants should send a CV and bibliography and an outline of a proposed research program (no more than two pages) to Ana Tarrinha at tarrinha@mail.nih.gov. The search will continue until a qualified applicant is found. Review of applicants will begin on or about October 1, 2011.